Surveillance Colonoscopy Is Cost-Effective for Patients With Adenomas Who Are at High Risk of Colorectal Cancer

Gastroenterology

Volumn 138, Issue 7, 2010, Pages

  Saini, Sameer D ^a,b   Schoenfeld, Philip ^a,b   Vijan, Sandeep ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer Screening; Cost Utility Analysis; Overuse; Risk Stratification

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; STATISTICAL MODEL;

EID: 77952751590     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.004     Document Type: Article

References (46)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
3. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
4. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
5. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008) 1570-1595
6. Lieberman D.A., De Garmo P.L., Fleischer D.E., et al. Patterns of endoscopy use in the United States. Gastroenterology 118 (2000) 619-624
7. Lieberman D.A., Holub J., Eisen G., et al. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc 62 (2005) 875-883
8. Rex D.K. Postpolypectomy and post-cancer resection surveillance. Rev Gastroenterol Disord 3 (2003) 202-209
9. Lieberman D.A., Weiss D.G., Harford W.V., et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 133 (2007) 1077-1085
10. Winawer S.J., Zauber A.G., O'Brien M.J., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328 (1993) 901-906
11. Robertson D.J., Greenberg E.R., Beach M., et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129 (2005) 34-41
12. Ransohoff D.F. Have we oversold colonoscopy?. Gastroenterology 129 (2005) 1815
13. Soetikno R.M., Kaltenbach T., Rouse R.V., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299 (2008) 1027-1035
14. Laiyemo A.O., Murphy G., Albert P.S., et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 148 (2008) 419-426
15. Martinez M.E., Baron J.A., Lieberman D.A., et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136 (2009) 832-841
16. Boolchand V., Olds G., Singh J., et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med 145 (2006) 654-659
17. Mysliwiec P.A., Brown M.L., Klabunde C.N., et al. Are physicians doing too much colonoscopy?. A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141 (2004) 264-271
18. Saini S.D., Nayak R.S., Kuhn L., et al. Why don't gastroenterologists follow colon polyp surveillance guidelines?: results of a national survey. J Clin Gastroenterol 43 (2009) 554-558
19. Niv Y., Hazazi R., Levi Z., et al. Screening colonoscopy for colorectal cancer in asymptomatic people: a meta-analysis. Dig Dis Sci 53 (2008) 3049-3054
20. Saini S.D., Kim H.M., and Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 64 (2006) 614-626
21. Brenner H., Hoffmeister M., Stegmaier C., et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 56 (2007) 1585-1589
22. Frazier A.L., Colditz G.A., Fuchs C.S., et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284 (2000) 1954-1961
23. Arias E. United States life tables, 2004. National vital statistics reports. National Center for Health Statistics 56 (2007)
24. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
25. Gatto N.M., Frucht H., Sundararajan V., et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 95 (2003) 230-236
26. Warren J.L., Klabunde C.N., Mariotto A.B., et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 150 (2009) 849-857 W152
27. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101 (2006) 343-350
28. Fryback D.G., and Lawrence Jr. W.F. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making 17 (1997) 276-284
29. Ness R.M., Holmes A.M., Klein R., et al. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 94 (1999) 1650-1657
30. Syngal S., Weeks J.C., Schrag D., et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 129 (1998) 787-796
31. Centers for Medicare and Medicaid Services. Physician Fee Schedule Lookup. http://www.cms.hhs.gov/PFSlookup/ Accessed July 5, 2009
32. Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment rates; and payments for graduate medical education for affiliated teaching hospitals in certain emergency situations Medicare and Medicaid programs: hospital conditions of participation; necessary provider designations of critical access hospitals. Interim and final rule with comment period. Fed Regist 72 (2007) 66579-67226
33. Brown M.L., Riley G.F., Potosky A.L., et al. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 37 (1999) 1249-1259
34. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP). http://hcupnet.ahrq.gov/ Accessed July 8, 2009
35. Sonnenberg A., Delco F., and Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133 (2000) 573-584
36. Briggs A.H., Claxton K., and Sculpher M.J. Decision modelling for health economic evaluation (2006), Oxford University Press
37. Arguedas M.R., Heudebert G.R., and Wilcox C.M. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis. Aliment Pharmacol Ther 15 (2001) 631-638
38. Becker F., Nusko G., Welke J., et al. Benefit-risk analysis of different risk-related surveillance schedules following colorectal polypectomy. Hepatogastroenterology 54 (2007) 2249-2258
39. DuPont A.W., Arguedas M.R., and Wilcox C.M. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. Aliment Pharmacol Ther 26 (2007) 431-441
40. Hassan C., Pickhardt P.J., Di Giulio E., et al. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy. Dis Colon Rectum 52 (2009) 964-971
41. Ransohoff D.F., Lang C.A., and Kuo H.S. Colonoscopic surveillance after polypectomy: considerations of cost effectiveness. Ann Intern Med 114 (1991) 177-182
42. Shaukat A., Parekh M., Lipscomb J., et al. Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?. Int J Technol Assess Health Care 25 (2009) 222-231
43. Whynes D.K., Walker A.R., and Hardcastle J.D. Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Econ 1 (1992) 53-60
44. Baxter N.N., Goldwasser M.A., Paszat L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009) 1-8
45. Singh H., Petersen L.A., and Thomas E.J. Understanding diagnostic errors in medicine: a lesson from aviation. Qual Saf Health Care 15 (2006) 159-164
46. Saitoh Y., Waxman I., West A.B., et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology 120 (2001) 1657-1665